Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Times and Sales (L&S)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.Ltd (H)

Weitere Meldungen

21:20		Prediction: Amazon Will Join Nvidia, Apple, and Alphabet in the $4 Trillion Club Before 2029
21:00		ASML vs. Taiwan Semiconductor: Which Semiconductor Monopoly Is the Safer Investment?
20:59		Syria's former dictator Bashar Assad was sentenced to death for crimes against his own people. But for many civil war survivors, it's not enough
20:45		Broadcom vs. Nvidia: 1 Critical Metric Shows Which Artificial Intelligence (AI) Chipmaker Is the Better Buy After Earnings
20:32		Will Eli Lilly Split Its Stock? Here's What History Says Will Happen If It Does.
20:26		I Went Shopping for My Ultimate Smart Home of the Future at IFA 2026
20:20		Venice Token, Near Protocol, Worldcoin Tokens Jump as AI Tailwinds Rise
20:15		Apple's First iPhone Under New CEO John Ternus Launches Sept. 9. Here's Whether It's Finally Time to Buy the Stock.
20:00		3 Things Too Many People Get Wrong About Spousal Social Security Benefits
19:53		Why I Just Added to My Chevron Position Despite Trump Criticism
19:25		With AI Revenue Set to Surge 400% Over the Next 2 Years, Broadcom Stock Looks Like a Buy on Recent Dip
19:15		Ethereum Price Maps a Bullish Flag and Golden Cross as ETHB ETF Inflows Soar
19:00		Ares Capital Fell Enough to Push Its Yield Near 10%. Here's the Number That Actually Worries Me.
18:51		Tech-Branche streicht mehr Stellen: KI-Boom fordert Zehntausende Jobs
18:45		Anthropic Could Be the Next Mega IPO: 2 Magnificent Stocks That Already Own a Piece of the AI Unicorn
18:30		This Week in Tesla: Elon Musk Touts 'Golden Era' With Cybercab Amid Fleet Expansion
18:02		Kraken Robotics Stock Is Down 55% -- Is September the Month to Buy the Dip?
17:52		Anthropic Weighs Lockup Periods Longer Than the Standard 180 Days. Here's Why That Matters.
17:30		Ameren SVP Finance Ryan Martin Sells 971 Shares for $107,000
17:03		I'm 58 And Lost 10 Years As Mom's Full-Time Caregiver While My Sister Who Never Visited Got 100% of the $800K Inheritance — Now What?
17:00		Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?
16:45		Sundar Pichai's Gemini App Grew From 400 Million to Over 1 Billion Monthly Users in a Little Over a Year. Does That Adoption Curve Justify Alphabet's AI Spending Binge?
16:35		Why Deere Stock Hit an All-Time High This Week
16:30		Here's Why USA Rare Earth Is a Buy Before Its Next Earnings Report
16:25		There Are Only a Handful of S&P 500 Stocks That Yield Over 5%. Here's My Top Pick to Buy in September.
16:15		Warren Buffett Called Today's Stock Market 'a Church with a Casino Attached,' Warning That 'We've Never Had People in a More Gambling Mood Than Now.' Does History Say Investors Should Pull Back?
16:09		Most Investors Overpay for AI Hype. Nvidia Is the Exception.
16:03		Masked anti-migrant protesters block UK's Dover terminal
15:44		3 Incredible High-Growth Stocks to Buy With $10,000 Right Now
15:30		If You Buy Amazon With $10,000 at a 10% Discount From Its High, Here's What I Predict It Could Be Worth in 10 Years
15:25		LULU, AVGO, DELL, SNOW, GOOGL: 5 Stocks Investors Couldn't Stop Buzzing About This Week
15:15		Chevron's Iraq Bet Isn't the Real Dividend Growth Story. Here's What Is.
15:08		Welcome to Your Keyboard-Free Future. This Jazzy AI Microphone Is All You Need Now
15:06		Are Stocks Going to Plunge if Congress Is Split Under President Donald Trump? Here's What History Says About Stock Market Returns in This Scenario.
15:05		Zweite Generation des MacBook Neo: Drei Änderungen geplant
14:37		Why UiPath Rallied in August
14:30		Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.
14:07		SoFi Raised Its Revenue Guidance and the Stock Fell 10%. Here's What the Market Missed.
14:01		Benzinga Bulls and Bears: Palo Alto, Ciena, Lululemon
14:00		Why does almost nobody want to befriend older people like me — except scammers?
13:45		Recent News From Nvidia and SK Hynix Reveals Exactly What the Market Expects for Micron Technology's Future
13:30		Insiders and Early Investors Are Selling SpaceX Stock and Index Funds Are Buying It. Which Side Do You Want to Be On?
13:23		Dyson Went Bonkers During IFA 2026: Here Are all 10 of Its New Products
13:20		Realty Income Is Paying More Dividends Than Ever Before and Yields 5.3%. Here's Why Its High-Yield Monthly Payout Is as Safe as It Gets.
13:18		BSI warnt nach Daten-Leak vor erhöhter Cyber-Bedrohung
13:15		Should You Buy Canopy Growth Stock on the Rebound?
13:11		Nvidia Just Doubled Its Revenue. Here's Why the Stock Has Underperformed Its Peers.
13:05		Even With the S&P 500 at All-Time Highs, I'd Buy This High-Yield Dividend Stock Without Any Hesitation in September.
12:36		Social Security's Trump Bump-Driven 2027 COLA Comes With Potentially Serious Unintended Consequences
12:30		I Love Bloom Energy for 1 Reason, and It's Not the Backlog

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: China Citic Bank a Shandong Weigao Group Medical Polymer Anhui Tianda Oil Pipe Company Anhui Conch Cement Hainan Meilan International Airport

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	05.09.2026 21:45
Kaufwert:	EUR
	Hinzufügen Speichern

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Aktie

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Times and Sales (L&S)

Times and Sales

Analysen zu Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.Ltd (H)

Weitere Meldungen